Oxadiazole benzenesulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
A Standard patent application filed on 03 June 1997 credited to Biftu, Tesfaye
;
Feng, Danqing Dennis
;
Fisher, Michael H.
;
Naylor, Elizabeth M
;
Liang, Gui-Bai
;
Weber, Ann E.
;
Kuo, Chan-Hwa
Details
Application number :
33748
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Oxadiazole benzenesulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
Inventor :
Biftu, Tesfaye
;
Feng, Danqing Dennis
;
Fisher, Michael H.
;
Naylor, Elizabeth M
;
Liang, Gui-Bai
;
Weber, Ann E.
;
Kuo, Chan-Hwa
Agent name :
SPRUSON & FERGUSON
Address for service :
GPO Box 3898 SYDNEY NSW 2001
Filing date :
03 June 1997
Associated companies :
Applicant name :
Merck & Co., Inc.
Applicant address :
126 East Lincoln Avenue Rahway NJ 07065 United States of America